MedTrace Logo

Rapid Diagnostic Supporting Antimicrobial Stewardship in Patients With Pneumonia

NCT05937126 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1203

Last updated 2023-07-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether or not the FilmArray Penumonia Panel adds value to patient care.

Conditions

Interventions

DIAGNOSTIC_TEST

FilmArray Pneumonia Panel

FDA-approved/cleared molecular, multiplex device that rapidly identifies viruses, bacteria, and antimicrobial resistance genes in sputum-like and bronchoalveolar lavage (BAL)-like specimens obtained from individuals with signs of a lower respiratory tract infection.

DIAGNOSTIC_TEST

Culture and antimicrobial susceptibility testing

Standard of care Gram stain, culture and other clinically ordered tests will be performed per standard practice.

Sponsors & Collaborators

Principal Investigators

  • Robin Patel, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2022-09-19
Completion
2022-09-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05937126 on ClinicalTrials.gov